• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Belinostat

CAS No. 866323-14-0

Belinostat ( PXD101 | PX105684 | PXD-101 | PXD 101 | PX-105684 )

产品货号. M16294 CAS No. 866323-14-0

一种有效的 HDAC 抑制剂,IC50 为 27 nM。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥373 有现货
10MG ¥603 有现货
25MG ¥918 有现货
50MG ¥1386 有现货
100MG ¥1962 有现货
200MG ¥3132 有现货
500MG ¥5004 有现货
1G 获取报价 有现货
1 mL x 10 mM in DMSO ¥143 有现货

生物学信息

  • 产品名称
    Belinostat
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    一种有效的 HDAC 抑制剂,IC50 为 27 nM。
  • 产品描述
    A potent HDAC inhibitor with IC50 of 27 nM (HeLa cell extracts); inhibits histone deacetylase activity in cell lysates with IC50 of 9-100 nM, increases the acetylation of histone H4 and induces apoptosis in tumor cell lines; inhibits the growth of a range of human tumor cell lines in vitro (IC50=0.2-3.4 uM); shows antitumor activity in vivo with no apparent toxicity.Blood Cancer Approved.
  • 体外实验
    Belinostat (PXD101) induces a concentration-dependent (0.2-5 μM) increase in acetylation of histone H4 in tumor cell lines. Belinostat is cytotoxic in vitro in a number of tumor cell lines with IC50s in the range 0.2-3.4 μM as determined by a clonogenic assay and induces apoptosis. Belinostat inhibits the growth of a number of human tumor cell lines in vitro with IC50s determined by a clonogenic assay in the range 0.2-3.4 μM. Belinostat (PXD101) is a potent histone deacetylase (HDAC) inhibitor, potently inhibits the enzymatic activity of purified recombinant HDAC6 (IC50 of 82 nM).
  • 体内实验
    Treatment of nude mice bearing human ovarian and colon tumor xenografts with Belinostat (10-40 mg/kg/day i.p.) daily for 7 days causes a significant dose-dependent growth delay with no obvious signs of toxicity to the mice. Growth delay is also observed for xenografts of cisplatin-resistant ovarian tumor cells. A marked increase in acetylation of H4 is detected in blood and tumor of mice 3 h after treatment with Belinostat (PXD101). The inhibition of growth of human tumor xenografts in mice, with no apparent toxicity. Belinostat (PXD101) displays single-agent antitumor activity on human A2780 ovarian cancer s.c. xenografts which is enhanced via combination therapy with Carboplatin.
  • 同义词
    PXD101 | PX105684 | PXD-101 | PXD 101 | PX-105684
  • 通路
    Cell Cycle/DNA Damage
  • 靶点
    HDAC
  • 受体
    HDAC
  • 研究领域
    Cancer
  • 适应症
    Blood cancer

化学信息

  • CAS Number
    866323-14-0
  • 分子量
    318.3477
  • 分子式
    C15H14N2O4S
  • 纯度
    >98% (HPLC)
  • 溶解度
    10 mM in DMSO
  • SMILES
    O=C(NO)/C=C/C1=CC=CC(S(=O)(NC2=CC=CC=C2)=O)=C1
  • 化学全称
    2-Propenamide, N-hydroxy-3-[3-[(phenylamino)sulfonyl]phenyl]-, (2E)-

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Plumb JA, et al. Mol Cancer Ther. 2003 Aug;2(8):721-8. 2. Qian X, et al. Mol Cancer Ther. 2006 Aug;5(8):2086-95. 3. Buckley MT, et al. J Transl Med. 2007 Oct 12;5:49.
产品手册
关联产品
  • BRD-73954

    第一个 HDAC6/8 双抑制剂,IC50 为 36/120 nM。

  • CUDC-907

    CUDC-907 有效抑制 I 类 PI3K 以及 I 类和 II 类 HDAC 酶。

  • Remetinostat

    Remetinostat 是一种基于异羟肟酸的组蛋白脱乙酰酶抑制剂。